France completes Lovenox recall
This article was originally published in Scrip
Executive Summary
All packs of Sanofi-Aventis's Lovenox (enoxaparin) that were distributed before May have now been removed from the French market, the regulator Afssaps says. The low-molecular weight heparin (LMWH) product was caught up in a worldwide contamination scare earlier this year, but a shortage of suitable replacements led the agency to recommend a phased withdrawal of products it deemed low-risk (Scrip Online, April 25th, 2008).